News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
421,999 Results
Type
Article (24655)
Company Profile (255)
Press Release (397089)
Section
Business (123469)
Career Advice (431)
Deals (20580)
Drug Delivery (72)
Drug Development (49139)
Employer Resources (76)
FDA (11714)
Job Trends (10034)
News (208163)
Policy (20130)
Tag
Academia (2110)
Alliances (34494)
Alzheimer's disease (857)
Approvals (11703)
Artificial intelligence (131)
Bankruptcy (132)
Best Places to Work (8928)
Biotechnology (185)
Breast cancer (145)
Cancer (1036)
Cardiovascular disease (88)
Career advice (383)
CAR-T (71)
Cell therapy (218)
Clinical research (40110)
Collaboration (443)
Compensation (142)
COVID-19 (1649)
C-suite (97)
Data (1140)
Diabetes (128)
Diagnostics (4205)
Earnings (42655)
Events (63383)
Executive appointments (349)
FDA (12257)
Funding (363)
Gene therapy (159)
GLP-1 (422)
Government (3285)
Healthcare (13756)
Infectious disease (1714)
Inflammatory bowel disease (93)
IPO (9313)
Job creations (1572)
Job search strategy (350)
Layoffs (184)
Legal (3337)
Lung cancer (148)
Lymphoma (76)
Manufacturing (166)
Medical device (10067)
Medtech (10069)
Mergers & acquisitions (11480)
Metabolic disorders (331)
Neuroscience (1080)
NextGen Class of 2024 (4207)
Non-profit (3208)
Northern California (1185)
Obesity (195)
Opinion (116)
Patents (87)
People (38338)
Phase I (11745)
Phase II (16846)
Phase III (14565)
Pipeline (365)
Postmarket research (1718)
Preclinical (4523)
Radiopharmaceuticals (223)
Rare diseases (195)
Real estate (3522)
Regulatory (14533)
Research institute (1884)
Southern California (991)
Startups (2458)
United States (11175)
Vaccines (352)
Weight loss (120)
Date
Last 7 days (467)
Last 30 days (1820)
Last 365 days (26824)
2024 (26711)
2023 (29430)
2022 (37979)
2021 (40548)
2020 (37960)
2019 (33609)
2018 (25363)
2017 (22479)
2016 (21176)
2015 (23587)
2014 (16946)
2013 (13756)
2012 (14626)
2011 (14438)
2010 (12557)
Location
Africa (418)
Arizona (72)
Asia (25941)
Australia (3815)
California (2641)
Canada (1197)
China (269)
Colorado (133)
Connecticut (142)
Delaware (71)
Europe (60556)
Florida (400)
Georgia (100)
Illinois (307)
Indiana (200)
Japan (77)
Maryland (426)
Massachusetts (2271)
Michigan (98)
Minnesota (198)
New Jersey (904)
New York (812)
North Carolina (608)
Northern California (1185)
Ohio (112)
Pennsylvania (682)
South America (574)
Southern California (991)
Texas (372)
Utah (82)
Washington State (294)
421,999 Results for "innovative medicines canada".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Innovative Medicines Canada Urges Provinces to Accelerate Access to Medicines
July 17, 2024
·
2 min read
Press Releases
Health Canada approves Celltrion’s Omlyclo™ (CT-P39), the first and only omalizumab biosimilar in Canada
December 9, 2024
·
3 min read
Biotech Beach
QuidelOrtho Receives Health Canada Approval for Quidel® Triage® PLGF Test for Laboratory Use in Canada
QuidelOrtho Corporation (Nasdaq:QDEL) (“QuidelOrtho”), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has received approval from Health Canada for its Triage PLGF test for laboratory use in Canada.
March 6, 2024
·
4 min read
Press Releases
OBIO® and CATTI Collaborate to Boost Canada’s Biomanufacturing Capacity for Advanced Therapies
November 4, 2024
·
3 min read
Press Releases
Takeda Sponsors MILESTONE Canada Advanced Inflammatory Bowel Disease (IBD) Fellowship Initiative
December 19, 2024
·
4 min read
Press Releases
Theratechnologies Announces Exclusive Licensing Agreement with Ionis to Commercialize Olezarsen and Donidalorsen in Canada
December 4, 2024
·
9 min read
Press Releases
BeiGene Canada Proud National Sponsor of the Leukemia & Lymphoma Society of Canada’s 2024 Light The Night
October 21, 2024
·
2 min read
Press Releases
Canada’s Drug Agency Recommends WINREVAIR® (sotatercept) for Reimbursement
November 11, 2024
·
4 min read
Biotech Bay
Scilex Holding Company Provides Responses to Product Composition Questions Related to its ELYXYB® Patent in Canada for a New Drug Submission Under Review by Health Canada for the Approval of ELYXYB®
Scilex Holding Company today announced that it has responded to questions on the product composition in the ELYXYB patent from Health Canada’s Office of Patented Medicines and Liaison (OPML) during review of a New Drug Submission (“NDS”) to Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for the approval of ELYXYB® for acute treatment of migraine with or without aura in Canada.
March 18, 2024
·
7 min read
Press Releases
Theralase(R) Launches New Clinical Study Site in Canada
December 6, 2024
·
9 min read
1 of 42,200
Next
